BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
CXCL2
,
T cell receptor signaling pathway
,
Influenza
,
Hypothalamus
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD4/CD8 ratio
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for CD4/CD8 ratio
Explore Curated Studies Results
Literature
Most Relevant Literature
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS…
Bayesian semiparametric growth models for measurement error and missing data in CD4/CD8 ratio: Appli…
Cerebrospinal fluid CD4+ /CD8+ ratio in diagnosing neurosarcoidosis.
Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the …
Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio
Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay…
Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Ther…
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negat…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ